Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472314 · ClinicalTrials.gov registry record · Phase 4
Exparel for Postoperative Pain Management in Shoulder Surgery
A Phase 4 study of Fracture of Shoulder and Upper Arm, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT02472314 is a Phase 4 study of Fracture of Shoulder and Upper Arm that has completed, run by Wayne State University. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02472314, a Phase 4 study of Fracture of Shoulder and Upper Arm, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.
Conditions Studied
Interventions
- DRUG 1.3% Liposomal Bupivacaine
- DRUG 0.125% Bupivacaine
Study Locations (1)
Michigan
- Wayne State University Physician Group - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02472314
The ClinicalTrials.gov registry entry for NCT02472314 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fracture of Shoulder and Upper Arm appearing as the primary indexed condition, and to 2 interventions - of which 1.3% Liposomal Bupivacaine is the first listed.
NCT02472314 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02472314 about?
NCT02472314 is a clinical study titled "Exparel for Postoperative Pain Management in Shoulder Surgery". The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.
What is the current status of trial NCT02472314?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2015-06. Estimated completion is 2017-05.
What conditions does trial NCT02472314 study?
This clinical trial studies the following conditions: Fracture of Shoulder and Upper Arm.
What interventions are being tested in trial NCT02472314?
The interventions under investigation include: 1.3% Liposomal Bupivacaine (DRUG), 0.125% Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02472314?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02472314 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.